Eli Lilly (LLY) PT Raised to $358 at BMO Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,273.46 -2.54%
Rating Summary:
31 Buy, 4 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Rating Summary:
31 Buy, 4 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Join SI Premium – FREE
BMO Capital analyst Evan David Seigerman raised the price target on Eli Lilly (NYSE: LLY) to $358.00 (from $330.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Eli Lilly & Co. (LLY) call put ratio 1 call to 1 put into quarter results
- Lilly presents first clinical data in platinum-sensitive ovarian cancer for its investigational, next-generation, FRĪ±-targeting ADC at ESMO 2026
- Cheesecake Factory (CAKE) PT Raised to $80 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
